{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T04:05:01Z","timestamp":1789704301901,"version":"4.0.1"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,3,1]],"date-time":"2016-03-01T00:00:00Z","timestamp":1456790400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","atherosclerosis-journal.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Atherosclerosis"],"published-print":{"date-parts":[[2016,3]]},"DOI":"10.1016\/j.atherosclerosis.2015.12.040","type":"journal-article","created":{"date-parts":[[2015,12,29]],"date-time":"2015-12-29T05:48:36Z","timestamp":1451368116000},"page":"71-77","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"special_numbering":"C","title":["Brain microangiopathy and macroangiopathy share common risk factors and biomarkers"],"prefix":"10.1016","volume":"246","author":[{"given":"Oh Young","family":"Bang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9200-8899","authenticated-orcid":false,"given":"Jong-Won","family":"Chung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sookyung","family":"Ryoo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gyeong Joon","family":"Moon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gyeong-Moon","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chin-Sang","family":"Chung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kwang Ho","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.atherosclerosis.2015.12.040_bib1","doi-asserted-by":"crossref","first-page":"27","DOI":"10.5853\/jos.2013.15.1.27","article-title":"Biomarkers for stroke","volume":"15","author":"Kim","year":"2013","journal-title":"J.\u00a0Stroke"},{"issue":"7","key":"10.1016\/j.atherosclerosis.2015.12.040_bib2","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1111\/ijs.12496","article-title":"A\u00a0pathological perspective on the natural history of cerebral atherosclerosis","volume":"10","author":"Gutierrez","year":"2015","journal-title":"Int. J. Stroke"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2015.12.040_bib3","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1161\/STROKEAHA.112.664680","article-title":"High-resolution magnetic resonance imaging: an emerging tool for evaluating intracranial arterial disease","volume":"44","author":"Bodle","year":"2013","journal-title":"Stroke"},{"issue":"2","key":"10.1016\/j.atherosclerosis.2015.12.040_bib4","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1212\/01.wnl.0000168862.09764.9f","article-title":"Association of the metabolic syndrome with intracranial atherosclerotic stroke","volume":"65","author":"Bang","year":"2005","journal-title":"Neurology"},{"issue":"22","key":"10.1016\/j.atherosclerosis.2015.12.040_bib5","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.1212\/01.wnl.0000263186.20988.9f","article-title":"Adiponectin levels in patients with intracranial atherosclerosis","volume":"68","author":"Bang","year":"2007","journal-title":"Neurology"},{"issue":"10","key":"10.1016\/j.atherosclerosis.2015.12.040_bib6","doi-asserted-by":"crossref","first-page":"2712","DOI":"10.1161\/STROKEAHA.112.661702","article-title":"Biological signatures of asymptomatic extra- and intracranial atherosclerosis: the Barcelona-AsIA (Asymptomatic Intracranial Atherosclerosis) study","volume":"43","author":"Lopez-Cancio","year":"2012","journal-title":"Stroke"},{"issue":"5","key":"10.1016\/j.atherosclerosis.2015.12.040_bib7","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1161\/STROKEAHA.107.498600","article-title":"Progression of symptomatic intracranial large artery atherosclerosis is associated with a proinflammatory state and impaired fibrinolysis","volume":"39","author":"Arenillas","year":"2008","journal-title":"Stroke"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2015.12.040_bib8","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.atherosclerosis.2011.04.031","article-title":"Lipoprotein-associated phospholipase A2 testing usefulness among patients with symptomatic intracranial atherosclerotic disease","volume":"218","author":"Massot","year":"2011","journal-title":"Atherosclerosis"},{"issue":"2","key":"10.1016\/j.atherosclerosis.2015.12.040_bib9","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1016\/j.atherosclerosis.2010.07.007","article-title":"Elevated serum lipoprotein(a) as a potential predictor for combined intracranial and extracranial artery stenosis in patients with ischemic stroke","volume":"212","author":"Kim","year":"2010","journal-title":"Atherosclerosis"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2015.12.040_bib10","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1212\/01.WNL.0000132637.30287.B4","article-title":"High lipoprotein (a), diabetes, and the extent of symptomatic intracranial atherosclerosis","volume":"63","author":"Arenillas","year":"2004","journal-title":"Neurology"},{"issue":"12","key":"10.1016\/j.atherosclerosis.2015.12.040_bib11","doi-asserted-by":"crossref","first-page":"2478","DOI":"10.1161\/01.STR.29.12.2478","article-title":"Relation of plasma homocyst(e)ine to cerebral infarction and cerebral atherosclerosis","volume":"29","author":"Yoo","year":"1998","journal-title":"Stroke"},{"issue":"7","key":"10.1016\/j.atherosclerosis.2015.12.040_bib12","doi-asserted-by":"crossref","first-page":"1952","DOI":"10.1161\/STROKEAHA.107.508135","article-title":"Biomarkers of inflammation and MRI-defined small vessel disease of the brain: the cardiovascular health study","volume":"39","author":"Fornage","year":"2008","journal-title":"Stroke"},{"issue":"2","key":"10.1016\/j.atherosclerosis.2015.12.040_bib13","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1002\/ana.10644","article-title":"Frequency and mechanisms of stroke recurrence after cryptogenic stroke","volume":"54","author":"Bang","year":"2003","journal-title":"Ann. Neurol."},{"issue":"12","key":"10.1016\/j.atherosclerosis.2015.12.040_bib14","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1212\/WNL.0b013e31824c4699","article-title":"Branch occlusive disease: clinical and magnetic resonance angiography findings","volume":"78","author":"Ryoo","year":"2012","journal-title":"Neurology"},{"issue":"9","key":"10.1016\/j.atherosclerosis.2015.12.040_bib15","first-page":"549","article-title":"High performance liquid chromatography method for rapid and accurate determination of homocysteine in plasma and serum","volume":"29","author":"Vester","year":"1991","journal-title":"Eur. J. Clin. Chem. Clin. Biochem."},{"issue":"4","key":"10.1016\/j.atherosclerosis.2015.12.040_bib16","first-page":"643","article-title":"A\u00a0standardized method for measuring intracranial arterial stenosis","volume":"21","author":"Samuels","year":"2000","journal-title":"AJNR Am. J. Neuroradiol."},{"issue":"2","key":"10.1016\/j.atherosclerosis.2015.12.040_bib17","doi-asserted-by":"crossref","first-page":"351","DOI":"10.2214\/ajr.149.2.351","article-title":"MR signal abnormalities at 1.5 T in Alzheimer's dementia and normal aging","volume":"149","author":"Fazekas","year":"1987","journal-title":"AJR Am. J. Roentgenol."},{"issue":"7","key":"10.1016\/j.atherosclerosis.2015.12.040_bib18","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1212\/WNL.0b013e318281ccc2","article-title":"Large-vessel correlates of cerebral small-vessel disease","volume":"80","author":"Brisset","year":"2013","journal-title":"Neurology"},{"key":"10.1016\/j.atherosclerosis.2015.12.040_bib19","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1186\/1471-2458-8-117","article-title":"Prevalence of chronic kidney disease in population-based studies: systematic review","volume":"8","author":"Zhang","year":"2008","journal-title":"BMC Public Health"},{"issue":"8","key":"10.1016\/j.atherosclerosis.2015.12.040_bib20","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1111\/eci.12113","article-title":"Epidemiology and risk factors for chronic kidney disease in patients with ischaemic stroke","volume":"43","author":"Bao","year":"2013","journal-title":"Eur. J. Clin. Investig."},{"issue":"8","key":"10.1016\/j.atherosclerosis.2015.12.040_bib21","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1016\/S1474-4422(14)70026-2","article-title":"Stroke and cerebrovascular diseases in patients with chronic kidney disease","volume":"13","author":"Toyoda","year":"2014","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.atherosclerosis.2015.12.040_bib22","doi-asserted-by":"crossref","first-page":"306189","DOI":"10.4061\/2011\/306189","article-title":"Clinical Interaction between brain and kidney in small vessel disease","volume":"2011","author":"Mogi","year":"2011","journal-title":"Cardiol. Res. Pract."},{"issue":"1","key":"10.1016\/j.atherosclerosis.2015.12.040_bib23","doi-asserted-by":"crossref","first-page":"31","DOI":"10.5853\/jos.2015.17.1.31","article-title":"Cerebral small vessel disease and chronic kidney disease","volume":"17","author":"Toyoda","year":"2015","journal-title":"J.\u00a0Stroke"},{"issue":"7","key":"10.1016\/j.atherosclerosis.2015.12.040_bib24","doi-asserted-by":"crossref","first-page":"1782","DOI":"10.1016\/S0735-1097(01)01627-8","article-title":"Renal function: the Cinderella of cardiovascular risk profile","volume":"38","author":"Ruilope","year":"2001","journal-title":"J.\u00a0Am. Coll. Cardiol."},{"issue":"5","key":"10.1016\/j.atherosclerosis.2015.12.040_bib25","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1093\/ndt\/gfg080","article-title":"Impaired renal function is associated with markers of endothelial dysfunction and increased inflammatory activity","volume":"18","author":"Stam","year":"2003","journal-title":"Nephrol. Dial. Transpl."},{"issue":"1","key":"10.1016\/j.atherosclerosis.2015.12.040_bib26","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.atherosclerosis.2012.01.043","article-title":"Endothelial dysfunction and cardiovascular disease in early-stage chronic kidney disease: cause or association?","volume":"223","author":"Moody","year":"2012","journal-title":"Atherosclerosis"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2015.12.040_bib27","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.atherosclerosis.2014.02.006","article-title":"Chronic kidney disease, lipids and apolipoproteins, and coronary heart disease: the ARIC study","volume":"234","author":"Lamprea-Montealegre","year":"2014","journal-title":"Atherosclerosis"},{"issue":"2","key":"10.1016\/j.atherosclerosis.2015.12.040_bib28","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1681\/ASN.2005080834","article-title":"Endothelial dysfunction contributes to renal function-associated cardiovascular mortality in a population with mild renal insufficiency: the Hoorn study","volume":"17","author":"Stam","year":"2006","journal-title":"J.\u00a0Am. Soc. Nephrol."},{"issue":"2","key":"10.1016\/j.atherosclerosis.2015.12.040_bib29","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1053\/j.ajkd.2003.10.037","article-title":"Inflammation, endothelial dysfunction, and platelet activation in patients with chronic kidney disease: the chronic renal impairment in Birmingham (CRIB) study","volume":"43","author":"Landray","year":"2004","journal-title":"Am. J. Kidney Dis."},{"issue":"6","key":"10.1016\/j.atherosclerosis.2015.12.040_bib30","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1161\/HYPERTENSIONAHA.114.04221","article-title":"Endothelial dysfunction plays a key role in increasing cardiovascular risk in type 2 diabetes: the Hoorn study","volume":"64","author":"van Sloten","year":"2014","journal-title":"Hypertension"},{"issue":"4","key":"10.1016\/j.atherosclerosis.2015.12.040_bib31","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1111\/j.1523-1755.2002.kid571.x","article-title":"Mild renal insufficiency is associated with increased cardiovascular mortality: the Hoorn Study","volume":"62","author":"Henry","year":"2002","journal-title":"Kidney Int."},{"issue":"9","key":"10.1016\/j.atherosclerosis.2015.12.040_bib32","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1056\/NEJMoa1204133","article-title":"Effects of clopidogrel added to aspirin in patients with recent lacunar stroke","volume":"367","author":"Benavente","year":"2012","journal-title":"N.\u00a0Engl. J. Med."},{"issue":"13","key":"10.1016\/j.atherosclerosis.2015.12.040_bib33","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1056\/NEJMoa043033","article-title":"Comparison of warfarin and aspirin for symptomatic intracranial arterial stenosis","volume":"352","author":"Chimowitz","year":"2005","journal-title":"N.\u00a0Engl. J. Med."},{"issue":"11","key":"10.1016\/j.atherosclerosis.2015.12.040_bib34","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1056\/NEJMoa1105335","article-title":"Stenting versus aggressive medical therapy for intracranial arterial stenosis","volume":"365","author":"Chimowitz","year":"2011","journal-title":"N.\u00a0Engl. J. Med."},{"issue":"3","key":"10.1016\/j.atherosclerosis.2015.12.040_bib35","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1053\/j.ajkd.2014.09.016","article-title":"Healthy lifestyle and risk of kidney disease progression, atherosclerotic events, and death in CKD: findings from the Chronic Renal Insufficiency Cohort (CRIC) Study","volume":"65","author":"Ricardo","year":"2015","journal-title":"Am. J. Kidney Dis."},{"issue":"9","key":"10.1016\/j.atherosclerosis.2015.12.040_bib36","doi-asserted-by":"crossref","first-page":"e44865","DOI":"10.1371\/journal.pone.0044865","article-title":"Differential risk factors for lacunar stroke depending on the MRI (white and red) subtypes of microangiopathy","volume":"7","author":"Park","year":"2012","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.atherosclerosis.2015.12.040_bib37","first-page":"183","article-title":"Endothelial dysfunction: cardiovascular risk factors, therapy, and outcome","volume":"1","author":"Hadi","year":"2005","journal-title":"Vasc. Health Risk Manag."},{"issue":"10","key":"10.1016\/j.atherosclerosis.2015.12.040_bib38","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1161\/CIRCULATIONAHA.106.652859","article-title":"Endothelial function and dysfunction: testing and clinical relevance","volume":"115","author":"Deanfield","year":"2007","journal-title":"Circulation"},{"issue":"12","key":"10.1016\/j.atherosclerosis.2015.12.040_bib39","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1016\/j.autrev.2010.07.017","article-title":"Effects of treatment strategy on endothelial function","volume":"9","author":"Tomasoni","year":"2010","journal-title":"Autoimmun. Rev."},{"issue":"11","key":"10.1016\/j.atherosclerosis.2015.12.040_bib40","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1016\/S1474-4422(12)70234-X","article-title":"Genetic risk factors for ischaemic stroke and its subtypes (the METASTROKE collaboration): a meta-analysis of genome-wide association studies","volume":"11","author":"Traylor","year":"2012","journal-title":"Lancet Neurol."}],"container-title":["Atherosclerosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915015302690?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915015302690?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,9,2]],"date-time":"2019-09-02T21:12:50Z","timestamp":1567458770000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021915015302690"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,3]]},"references-count":40,"alternative-id":["S0021915015302690"],"URL":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2015.12.040","relation":{},"ISSN":["0021-9150"],"issn-type":[{"value":"0021-9150","type":"print"}],"subject":[],"published":{"date-parts":[[2016,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Brain microangiopathy and macroangiopathy share common risk factors and biomarkers","name":"articletitle","label":"Article Title"},{"value":"Atherosclerosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2015.12.040","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}